US HB5645 | 2015-2016 | 114th Congress

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on July 6 2016 - 25% progression, died in committee
Action: 2016-07-06 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]

Summary

United States-Israel Alzheimer's Disease Cooperation Act This bill directs the Department of Health and Human Services (HHS) to establish a program of grants to support research on the development and commercialization of tools, treatments, and cures for Alzheimer's disease and other dementias. Supported projects must be joint ventures between U.S. and Israeli non-governmental entities or the U.S. and Israeli governments. HHS must establish an advisory board to monitor the method by which grants are awarded and to provide performance reviews of actions taken to carry out this bill.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

United States-Israel Alzheimer's Disease Cooperation Act

Sponsors


History

DateChamberAction
2016-07-06HouseReferred to the House Committee on Energy and Commerce.
2016-07-06HouseIntroduced in House

Subjects


US Congress State Sources


Bill Comments

feedback